Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment. uri icon

Overview

publication date

  • September 19, 2014

Research

keywords

  • Anticoagulants
  • Benzamides
  • Enoxaparin
  • Factor Xa Inhibitors
  • Pyridines
  • Venous Thromboembolism

Identity

Scopus Document Identifier

  • 84925884552

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2014.09.004

PubMed ID

  • 25497265

Additional Document Info

volume

  • 169

issue

  • 1